Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norman Relkin

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Neurosurgery|September 15, 2005
Surgical management of idiopathic normal-pressure hydrocephalusMarvin Bergsneider, Peter McL Black, Petra Klinge, et al.
Molecular Medicine (Cambridge, Mass.)|October 24, 2002
Human cerebrospinal fluid apolipoprotein E isoforms are apparently inefficient at complexing with synthetic Alzheimer's amyloid-[beta] peptide (A[beta] 1-40 ) in vitroZhongmin Zhou, Norman Relkin, Jorge Ghiso, et al.
Neurosurgery|September 15, 2005
The value of supplemental prognostic tests for the preoperative assessment of idiopathic normal-pressure hydrocephalusAnthony Marmarou, Marvin Bergsneider, Petra Klinge, et al.
Electrophoresis|September 5, 2002
Studies of potential cerebrospinal fluid molecular markers for Alzheimer's diseaseLeila H Choe, Michael J Dutt, Norman Relkin, et al.
Neurosurgery|September 15, 2005
Development of guidelines for idiopathic normal-pressure hydrocephalus: introductionAnthony Marmarou, Marvin Bergsneider, Norman Relkin, et al.
Neurosurgery|September 15, 2005
Diagnosing idiopathic normal-pressure hydrocephalusNorman Relkin, Anthony Marmarou, Petra Klinge, et al.
Neurosurgery|September 15, 2005
Outcome of shunting in idiopathic normal-pressure hydrocephalus and the value of outcome assessment in shunted patientsPetra Klinge, Anthony Marmarou, Marvin Bergsneider, et al.
Cell Reports|January 21, 2015
Network Diffusion Model of Progression Predicts Longitudinal Patterns of Atrophy and Metabolism in Alzheimer's DiseaseAshish Raj, Eve LoCastro, Amy Kuceyeski, et al.
Fluids and Barriers of the CNS|May 11, 2017
Cerebrospinal fluid Aβ42, t-tau, and p-tau levels in the differential diagnosis of idiopathic normal-pressure hydrocephalus: a systematic review and meta-analysisZhongyun Chen, Chunyan Liu, Jie Zhang, et al.
Electrophoresis|April 24, 2014
Longitudinal effects of intravenous immunoglobulin on Alzheimer's cerebrospinal fluid proteomeGilda Shayan, Basia Adamiak, Leila H Choe, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Neurosurgery|September 15, 2005
Surgical management of idiopathic normal-pressure hydrocephalusMarvin Bergsneider, Peter McL Black, Petra Klinge, et al.
Molecular Medicine (Cambridge, Mass.)|October 24, 2002
Human cerebrospinal fluid apolipoprotein E isoforms are apparently inefficient at complexing with synthetic Alzheimer's amyloid-[beta] peptide (A[beta] 1-40 ) in vitroZhongmin Zhou, Norman Relkin, Jorge Ghiso, et al.
Neurosurgery|September 15, 2005
The value of supplemental prognostic tests for the preoperative assessment of idiopathic normal-pressure hydrocephalusAnthony Marmarou, Marvin Bergsneider, Petra Klinge, et al.
Electrophoresis|September 5, 2002
Studies of potential cerebrospinal fluid molecular markers for Alzheimer's diseaseLeila H Choe, Michael J Dutt, Norman Relkin, et al.
Neurosurgery|September 15, 2005
Development of guidelines for idiopathic normal-pressure hydrocephalus: introductionAnthony Marmarou, Marvin Bergsneider, Norman Relkin, et al.
Neurosurgery|September 15, 2005
Diagnosing idiopathic normal-pressure hydrocephalusNorman Relkin, Anthony Marmarou, Petra Klinge, et al.
Neurosurgery|September 15, 2005
Outcome of shunting in idiopathic normal-pressure hydrocephalus and the value of outcome assessment in shunted patientsPetra Klinge, Anthony Marmarou, Marvin Bergsneider, et al.
Cell Reports|January 21, 2015
Network Diffusion Model of Progression Predicts Longitudinal Patterns of Atrophy and Metabolism in Alzheimer's DiseaseAshish Raj, Eve LoCastro, Amy Kuceyeski, et al.
Fluids and Barriers of the CNS|May 11, 2017
Cerebrospinal fluid Aβ42, t-tau, and p-tau levels in the differential diagnosis of idiopathic normal-pressure hydrocephalus: a systematic review and meta-analysisZhongyun Chen, Chunyan Liu, Jie Zhang, et al.
Electrophoresis|April 24, 2014
Longitudinal effects of intravenous immunoglobulin on Alzheimer's cerebrospinal fluid proteomeGilda Shayan, Basia Adamiak, Leila H Choe, et al.
Pageof 4